{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:51Z","timestamp":1787020851386,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300572"],"award-info":[{"award-number":["81300572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20181093"],"award-info":[{"award-number":["BK20181093"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK2011860"],"award-info":[{"award-number":["BK2011860"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic cystopathy (DCP) is a chronic complication of diabetes mainly within the submucosal and muscular layers of the bladder due to the hyperglycemia-induced ischemia. As no effective therapies are currently available, the administration of optimized mesenchymal stem cells (MSCs) provides a potential treatment of DCP. Thus far, new strategy, such as genetic modification of MSCs, has been developed and has shown promising outcomes of various disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was conducted using integrin-linked kinase (ILK) gene-modified bone marrow-derived stem cells (BMSCs) for streptozotocin (STZ)-induced diabetic cystopathy in a rat model. In total, 68 male Sprague-Dawley rats were randomized into five groups: sham control (control group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910); DCP model alone (DM group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910); DCP rats intravenously treated with BMSCs (BMSC group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916); DCP rats accepted adenoviral vector-infected BMSCs (Ad-null-BMSC group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916) and DCP rats accepted ILK adenoviral vector-infected BMSCs (Ad-ILK-BMSC group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916). Diabetic rats accepted cell transplantation in the experimental group (2 rats per group) were sacrificed for the bladder tissue on the third day, 7th day, and 14th day of treatment respectively ahead of schedule. At 4\u2009weeks after treatment, all rats in five groups accepted urodynamic studies to evaluate bladder function and were sacrificed for bladder tissue.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our data showed that the underactive bladder function was significantly improved in DCP rats intravenously treated with ILK gene-modified BMSCs compared to those in the DM, BMSCs, and Ad-null-BMSC group. Meanwhile, we found that gene-modified BMSC treatment significantly promoted the activation of the AKT\/GSK-3\u03b2 pathway by increasing phosphorylation and led to the enhancement of survival. In addition, the expression levels of angiogenesis-related protein vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and stromal cell-derived factor-1 (SDF-1) were significantly higher in the Ad-ILK-BMSC group than that in the DM, BMSCs, and Ad-null-BMSC group as assessed by enzyme-linked immunosorbent assay and western blot. As two indicators of vascular endothelial cell markers, the expression of von Willebrand factor (vWF) and CD31 by western blot and immunofluorescent staining revealed that the percentage of the vascular area of the bladder tissue significantly increased in Ad-ILK-BMSC group compared with the BMSCs and Ad-null-BMSC group on the 14th day of treatment. Histological and immunohistochemical staining (hematoxylin and eosin (HE), vWF, Ki67, and TUNNEL) on the bladder tissue revealed statistically different results between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ILK gene-modified BMSCs restored the bladder function and histological construction via promoting the process of angiogenesis and protecting cells from high glucose-associated apoptosis in STZ-induced DCP rat model, which provides a potential for the treatment of patients with DCP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01795-4","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T03:03:42Z","timestamp":1594350222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model"],"prefix":"10.1186","volume":"11","author":[{"given":"Yi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiduo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoliang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0610-2898","authenticated-orcid":false,"given":"Liucheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"issue":"4","key":"1795_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/1753-0407.12272","volume":"7","author":"Z Yuan","year":"2015","unstructured":"Yuan Z, Tang Z, He C, Tang W. Diabetic cystopathy: a review. J Diabetes. 2015;7(4):442\u20137.","journal-title":"J Diabetes"},{"issue":"6","key":"1795_CR2","first-page":"267","volume":"23","author":"CF Moller","year":"1976","unstructured":"Moller CF. Diabetic cystopathy. I: a clinical study of the frequency of bladder dysfunction in diabetics. Dan Med Bull. 1976;23(6):267\u201378.","journal-title":"Dan Med Bull"},{"issue":"12","key":"1795_CR3","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00120-003-0456-7","volume":"42","author":"C Hampel","year":"2003","unstructured":"Hampel C, Gillitzer R, Pahernik S, Melchior S, Thuroff JW. Diabetes mellitus and bladder function. What should be considered? Urologe A. 2003;42(12):1556\u201363.","journal-title":"Urologe A"},{"key":"1795_CR4","first-page":"219","volume":"10","author":"BM Inouye","year":"2018","unstructured":"Inouye BM, Hughes FM Jr, Jin H, Lutolf R, Potnis KC, Routh JC, Rouse DC, Foo WC, Purves JT. Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria. Res Rep Urol. 2018;10:219\u201325.","journal-title":"Res Rep Urol"},{"key":"1795_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fsurg.2018.00072","volume":"5","author":"NS Klee","year":"2018","unstructured":"Klee NS, McCarthy CG, Lewis S, McKenzie JL, Vincent JE, Webb RC. Urothelial senescence in the pathophysiology of diabetic bladder dysfunction-a novel hypothesis. Front Surg. 2018;5:72.","journal-title":"Front Surg"},{"issue":"5","key":"1795_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2174\/1573399812666161019162747","volume":"13","author":"J Gandhi","year":"2017","unstructured":"Gandhi J, Dagur G, Warren K, Smith NL, Khan SA. Genitourinary complications of diabetes mellitus: an overview of pathogenesis, evaluation, and management. Curr Diabetes Rev. 2017;13(5):498\u2013518.","journal-title":"Curr Diabetes Rev"},{"key":"1795_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.autneu.2014.06.007","volume":"185","author":"CL Langdale","year":"2014","unstructured":"Langdale CL, Thor KB, Marson L, Burgard EC. Maintenance of bladder innervation in diabetes: a stereological study of streptozotocin-treated female rats. Auton Neurosci. 2014;185:59\u201366.","journal-title":"Auton Neurosci"},{"issue":"1","key":"1795_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12894-017-0256-9","volume":"17","author":"S Yonekubo","year":"2017","unstructured":"Yonekubo S, Tatemichi S, Maruyama K, Kobayashi M. Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats. BMC Urol. 2017;17(1):64.","journal-title":"BMC Urol"},{"issue":"1","key":"1795_CR9","first-page":"11","volume":"15","author":"M Miyazato","year":"2013","unstructured":"Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Rev Urol. 2013;15(1):11\u201322.","journal-title":"Rev Urol"},{"issue":"Suppl 2","key":"1795_CR10","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.4111\/icu.2017.58.S2.S99","volume":"58","author":"TC Chai","year":"2017","unstructured":"Chai TC And T Kudze. New therapeutic directions to treat underactive bladder. Investig Clin Urol 2017;58(Suppl 2):S99-S106.","journal-title":"Investig Clin Urol"},{"issue":"6","key":"1795_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747\u201354.","journal-title":"Acta Pharmacol Sin"},{"key":"1795_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.biopha.2018.11.068","volume":"109","author":"R Luo","year":"2019","unstructured":"Luo R, Lu Y, Liu J, Cheng J, Chen Y. Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases. Biomed Pharmacother. 2019;109:2022\u201334.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1795_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13287-018-1070-3","volume":"9","author":"M Pokrywczynska","year":"2018","unstructured":"Pokrywczynska M, Jundzill A, Rasmus M, Adamowicz J, Balcerczyk D, Buhl M, Warda K, Buchholz L, Gagat M, Grzanka D, Drewa T. Understanding the role of mesenchymal stem cells in urinary bladder regeneration-a preclinical study on a porcine model. Stem Cell Res Ther. 2018;9(1):328.","journal-title":"Stem Cell Res Ther"},{"issue":"4 Suppl","key":"1795_CR14","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.juro.2008.04.076","volume":"180","author":"G Anumanthan","year":"2008","unstructured":"Anumanthan G, Makari JH, Honea L, Thomas JC, Wills ML, Bhowmick NA, Adams MC, Hayward SW, Matusik RJ, Brock JW 3rd, Pope JC. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol. 2008;180(4 Suppl):1778\u201383.","journal-title":"J Urol"},{"issue":"7","key":"1795_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00345-018-2247-1","volume":"36","author":"B Wiafe","year":"2018","unstructured":"Wiafe B, Adesida A, Churchill T, Metcalfe P. Mesenchymal stem cells inhibit hypoxia-induced inflammatory and fibrotic pathways in bladder smooth muscle cells. World J Urol. 2018;36(7):1157\u201365.","journal-title":"World J Urol"},{"issue":"10","key":"1795_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1089\/scd.2019.0198","volume":"29","author":"J Li","year":"2020","unstructured":"Li J, Li Z, Wang C, Xu H, Hu Y, Tan Z, Zhang F, Liu C, Yang M, Wang Y, Jin Y, Peng Z, Biswas S, Zhu L. The regulatory effect of VEGF-ax on rat bone marrow mesenchymal stem cells\u2019 angioblastic differentiation and its proangiogenic ability. Stem Cells Dev. 2020;29(10):667\u201377.","journal-title":"Stem Cells Dev"},{"issue":"7","key":"1795_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jcyt.2013.02.015","volume":"15","author":"C Gopinath","year":"2013","unstructured":"Gopinath C, Ponsaerts P, Fransen E, Boeykens N, Pauwels P, Wyndaele JJ. Smooth muscle cell transplantation improves bladder contractile function in streptozocin-induced diabetic rats. Cytotherapy. 2013;15(7):869\u201378.","journal-title":"Cytotherapy."},{"issue":"9","key":"1795_CR18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/scd.2011.0244","volume":"21","author":"H Zhang","year":"2012","unstructured":"Zhang H, Qiu X, Shindel AW, Ning H, Ferretti L, Jin X, Lin G, Lin CS, Lue TF. Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev. 2012;21(9):1391\u2013400.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"1795_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11934-015-0563-1","volume":"17","author":"A Kim","year":"2016","unstructured":"Kim A, Shin DM, Choo MS. Stem cell therapy for interstitial cystitis\/bladder pain syndrome. Curr Urol Rep. 2016;17(1):1.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"1795_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm.3028","volume":"19","author":"P Bianco","year":"2013","unstructured":"Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19(1):35\u201342.","journal-title":"Nat Med"},{"key":"1795_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.exger.2017.10.026","volume":"100","author":"G Olmos","year":"2017","unstructured":"Olmos G, Lopez-Ongil S, Torres MPR. Integrin-linked kinase: a new actor in the ageing process? Exp Gerontol. 2017;100:87\u201390.","journal-title":"Exp Gerontol"},{"issue":"1","key":"1795_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc1524","volume":"5","author":"G Hannigan","year":"2005","unstructured":"Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer. 2005;5(1):51\u201363.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1795_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2015.09.026","volume":"243","author":"JA Moraes","year":"2015","unstructured":"Moraes JA, Frony AC, Dias AM, Renovato-Martins M, Rodrigues G, Marcinkiewicz C, Assreuy J, Barja-Fidalgo C. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells. Atherosclerosis. 2015;243(2):477\u201385.","journal-title":"Atherosclerosis."},{"issue":"7","key":"1795_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/ndt\/gfl120","volume":"21","author":"M Ohnishi","year":"2006","unstructured":"Ohnishi M, Hasegawa G, Yamasaki M, Obayashi H, Fukui M, Nakajima T, Ichida Y, Ohse H, Mogami S, Yoshikawa T, Nakamura N. Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells. Nephrol Dial Transplant. 2006;21(7):1786\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"1795_CR25","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.12659\/MSM.902806","volume":"23","author":"H Lu","year":"2017","unstructured":"Lu H, Li Y, Zhang T, Liu M, Chi Y, Liu S, Shi Y. Salidroside reduces high-glucose-induced podocyte apoptosis and oxidative stress via upregulating heme oxygenase-1 (HO-1) expression. Med Sci Monit. 2017;23:4067\u201376.","journal-title":"Med Sci Monit"},{"issue":"2","key":"1795_CR26","first-page":"746","volume":"16","author":"F Zhang","year":"2018","unstructured":"Zhang F And F Guo. Effect of transplantation of cardiac stem cells overexpressing integrin-linked kinase on cardiac function of rats with acute myocardial infarction. Exp Ther Med 2018;16(2):746\u2013750.","journal-title":"Exp Ther Med"},{"issue":"3","key":"1795_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jcjd.2016.11.002","volume":"41","author":"Y Huang","year":"2017","unstructured":"Huang Y, Ding L, Shao Y, Chen Z, Shen B, Ma Y, Zhu L, Wei Z. Integrin-linked kinase improves functional recovery of diabetic cystopathy and mesenchymal stem cell survival and engraftment in rats. Can J Diabetes. 2017;41(3):312\u201321.","journal-title":"Can J Diabetes"},{"issue":"1","key":"1795_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13287-018-0830-4","volume":"9","author":"J Sohn","year":"2018","unstructured":"Sohn J, Lin H, Fritch MR, Tuan RS. Influence of cholesterol\/caveolin-1\/caveolae homeostasis on membrane properties and substrate adhesion characteristics of adult human mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):86.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"1795_CR29","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/j.1464-410X.2010.09507.x","volume":"107","author":"B Vahabi","year":"2011","unstructured":"Vahabi B, McKay NG, Lawson K, Sellers DJ. The role of c-kit-positive interstitial cells in mediating phasic contractions of bladder strips from streptozotocin-induced diabetic rats. BJU Int. 2011;107(9):1480\u20137.","journal-title":"BJU Int"},{"issue":"2","key":"1795_CR30","doi-asserted-by":"publisher","first-page":"e57477","DOI":"10.1371\/journal.pone.0057477","volume":"8","author":"L Ding","year":"2013","unstructured":"Ding L, Song T, Yi C, Huang Y, Yu W, Ling L, Dai Y, Wei Z. Transcutaneous electrical nerve stimulation (TENS) improves the diabetic cytopathy (DCP) via up-regulation of CGRP and cAMP. PLoS One. 2013;8(2):e57477.","journal-title":"PLoS One"},{"issue":"10","key":"1795_CR31","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/jbmr.3190","volume":"32","author":"M Dejaeger","year":"2017","unstructured":"Dejaeger M, Bohm AM, Dirckx N, Devriese J, Nefyodova E, Cardoen R, St-Arnaud R, Tournoy J, Luyten FP, Maes C. Integrin-linked kinase regulates bone formation by controlling cytoskeletal organization and modulating BMP and Wnt signaling in osteoprogenitors. J Bone Miner Res. 2017;32(10):2087\u2013102.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"1795_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1139\/Y10-052","volume":"88","author":"R Cianfrocca","year":"2010","unstructured":"Cianfrocca R, Rosano L, Spinella F, Di Castro V, Natali PG, Bagnato A. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase. Can J Physiol Pharmacol. 2010;88(8):796\u2013801.","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"1795_CR33","first-page":"1101","volume":"16","author":"W Zhao","year":"2018","unstructured":"Zhao W, Zhang X, Zang L, Zhao P, Chen Y, Wang X. ILK promotes angiogenic activity of mesenchymal stem cells in multiple myeloma. Oncol Lett. 2018;16(1):1101\u20136.","journal-title":"Oncol Lett"},{"issue":"1","key":"1795_CR34","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1038\/s41467-019-13220-3","volume":"10","author":"H Park","year":"2019","unstructured":"Park H, Yamamoto H, Mohn L, Ambuhl L, Kanai K, Schmidt I, Kim KP, Fraccaroli A, Feil S, Junge HJ, Montanez E, Berger W, Adams RH. Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy. Nat Commun. 2019;10(1):5243.","journal-title":"Nat Commun"},{"issue":"5","key":"1795_CR35","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1089\/ten.tea.2009.0625","volume":"16","author":"H Tian","year":"2010","unstructured":"Tian H, Bharadwaj S, Liu Y, Ma PX, Atala A, Zhang Y. Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A. 2010;16(5):1769\u201379.","journal-title":"Tissue Eng Part A"},{"key":"1795_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2019.02.011","volume":"221","author":"H Salehi-Pourmehr","year":"2019","unstructured":"Salehi-Pourmehr H, Rahbarghazi R, Mahmoudi J, Roshangar L, Chapple CR, Hajebrahimi S, Abolhasanpour N, Azghani MR. Intra-bladder wall transplantation of bone marrow mesenchymal stem cells improved urinary bladder dysfunction following spinal cord injury. Life Sci. 2019;221:20\u20138.","journal-title":"Life Sci"},{"issue":"3","key":"1795_CR37","doi-asserted-by":"publisher","first-page":"254 e1","DOI":"10.1016\/j.jpurol.2019.03.003","volume":"15","author":"B Wiafe","year":"2019","unstructured":"Wiafe B, Adesida AB, Churchill T, Kadam R, Carleton J, Metcalfe PD. Mesenchymal stem cell therapy inhibited inflammatory and profibrotic pathways induced by partial bladder outlet obstruction and prevented high-pressure urine storage. J Pediatr Urol. 2019;15(3):254 e1\u201310.","journal-title":"J Pediatr Urol"},{"issue":"3","key":"1795_CR38","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.juro.2010.10.033","volume":"185","author":"LL Woo","year":"2011","unstructured":"Woo LL, Tanaka ST, Anumanthan G, Pope JC, Thomas JC, Adams MC, Brock JW 3rd, Bhowmick NA. Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data. J Urol. 2011;185(3):1132\u20138.","journal-title":"J Urol"},{"key":"1795_CR39","doi-asserted-by":"publisher","first-page":"632902","DOI":"10.1155\/2015\/632902","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee S, Choi E, Cha MJ, Hwang KC. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxid Med Cell Longev. 2015;2015:632902.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"1795_CR40","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3727\/096368912X637488","volume":"21","author":"YS Song","year":"2012","unstructured":"Song YS, Lee HJ, Doo SH, Lee SJ, Lim I, Chang KT, Kim SU. Mesenchymal stem cells overexpressing hepatocyte growth factor (HGF) inhibit collagen deposit and improve bladder function in rat model of bladder outlet obstruction. Cell Transplant. 2012;21(8):1641\u201350.","journal-title":"Cell Transplant"},{"issue":"12","key":"1795_CR41","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s11064-017-2401-y","volume":"42","author":"W WenBo","year":"2017","unstructured":"WenBo W, Fei Z, YiHeng D, Wei W, TingMang Y, WenHao Z, QianRu L, HaiTao L. Human umbilical cord mesenchymal stem cells overexpressing nerve growth factor ameliorate diabetic cystopathy in rats. Neurochem Res. 2017;42(12):3537\u201347.","journal-title":"Neurochem Res"},{"issue":"9","key":"1795_CR42","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.109.870725","volume":"120","author":"L Ding","year":"2009","unstructured":"Ding L, Dong L, Chen X, Zhang L, Xu X, Ferro A, Xu B. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation. 2009;120(9):764\u201373.","journal-title":"Circulation."},{"issue":"8","key":"1795_CR43","doi-asserted-by":"publisher","first-page":"e12356","DOI":"10.1371\/journal.pone.0012356","volume":"5","author":"M Maydan","year":"2010","unstructured":"Maydan M, McDonald PC, Sanghera J, Yan J, Rallis C, Pinchin S, Hannigan GE, Foster LJ, Ish-Horowicz D, Walsh MP, Dedhar S. Integrin-linked kinase is a functional Mn2+\u2212dependent protein kinase that regulates glycogen synthase kinase-3beta (GSK-3beta) phosphorylation. PLoS One. 2010;5(8):e12356.","journal-title":"PLoS One"},{"issue":"Pt 19","key":"1795_CR44","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1242\/jcs.017996","volume":"121","author":"PC McDonald","year":"2008","unstructured":"McDonald PC, Fielding AB, Dedhar S. Integrin-linked kinase--essential roles in physiology and cancer biology. J Cell Sci. 2008;121(Pt 19):3121\u201332.","journal-title":"J Cell Sci"},{"issue":"1","key":"1795_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.onc.1204052","volume":"20","author":"C Tan","year":"2001","unstructured":"Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef\/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC\u2212\/\u2212 human colon carcinoma cells. Oncogene. 2001;20(1):133\u201340.","journal-title":"Oncogene."},{"issue":"1","key":"1795_CR46","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1038\/s41467-018-06906-7","volume":"9","author":"J Vaynberg","year":"2018","unstructured":"Vaynberg J, Fukuda K, Lu F, Bialkowska K, Chen Y, Plow EF, Qin J. Non-catalytic signaling by pseudokinase ILK for regulating cell adhesion. Nat Commun. 2018;9(1):4465.","journal-title":"Nat Commun"},{"issue":"2","key":"1795_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.105.595918","volume":"114","author":"SP Lee","year":"2006","unstructured":"Lee SP, Youn SW, Cho HJ, Li L, Kim TY, Yook HS, Chung JW, Hur J, Yoon CH, Park KW, Oh BH, Park YB, Kim HS. Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation. 2006;114(2):150\u20139.","journal-title":"Circulation."},{"issue":"1","key":"1795_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S1535-6108(03)00281-2","volume":"5","author":"C Tan","year":"2004","unstructured":"Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell. 2004;5(1):79\u201390.","journal-title":"Cancer Cell"},{"issue":"3","key":"1795_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/cvr\/cvr053","volume":"91","author":"JM Tang","year":"2011","unstructured":"Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY. VEGF\/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res. 2011;91(3):402\u201311.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1795_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00404-017-4560-0","volume":"297","author":"X Zhu","year":"2018","unstructured":"Zhu X, Li Y, Zhou R, Wang N, Kang S. Knockdown of E-cadherin expression of endometrial epithelial cells may activate Wnt\/beta-catenin pathway in vitro. Arch Gynecol Obstet. 2018;297(1):117\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"1795_CR51","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ejcts.2007.12.016","volume":"33","author":"M Boodhwani","year":"2008","unstructured":"Boodhwani M, Voisine P, Ruel M, Sodha NR, Feng J, Xu SH, Bianchi C, Sellke FW. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction. Eur J Cardiothorac Surg. 2008;33(4):645\u201350.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"1795_CR52","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1002\/term.2233","volume":"11","author":"G Odent Grigorescu","year":"2017","unstructured":"Odent Grigorescu G, Rosca AM, Preda MB, Tutuianu R, Simionescu M, Burlacu A. Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells. J Tissue Eng Regen Med. 2017;11(11):3241\u201352.","journal-title":"J Tissue Eng Regen Med"},{"issue":"1","key":"1795_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11684-011-0116-z","volume":"5","author":"R Jiang","year":"2011","unstructured":"Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med. 2011;5(1):94\u2013100.","journal-title":"Front Med"},{"issue":"11","key":"1795_CR54","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012;307(11):1169\u201377.","journal-title":"JAMA."},{"issue":"3","key":"1795_CR55","first-page":"1177","volume":"41","author":"M Devetzi","year":"2018","unstructured":"Devetzi M, Goulielmaki M, Khoury N, Spandidos DA, Sotiropoulou G, Christodoulou I, Zoumpourlis V. Geneticallymodified stem cells in treatment of human diseases: tissue kallikrein (KLK1) based targeted therapy (review). Int J Mol Med. 2018;41(3):1177\u201386.","journal-title":"Int J Mol Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01795-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01795-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01795-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T15:15:06Z","timestamp":1650208506000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01795-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1795"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01795-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments involving the use of animals were in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. All animal protocols were approved by the Ethics Committee of the Second Affiliated Hospital of Nanjing Medical University (reference number: IACUC-1601006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}